SEC filing · 8-K

Pelthos Therapeutics Inc.: Executive or director change

Pelthos Therapeutics stockholders approved the 2026 Equity Incentive Plan, elected eight directors, and ratified the company independent auditor at the annual meeting.

Filed October 1, 2026

Neutral news

What happened

Stockholders approved the Pelthos Therapeutics Inc. 2026 Equity Incentive Plan, which immediately replaced the 2023 plan.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov All documents of this filing

Back to Pelthos Therapeutics Inc.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.